• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preoperative staging and risk analysis in esophageal carcinoma.

作者信息

Siewert J R, Hölscher A H, Dittler H J

机构信息

Department of Surgery, Technical University of Munich, FRG.

出版信息

Hepatogastroenterology. 1990 Aug;37(4):382-7.

PMID:2210604
Abstract

In esophageal cancer surgery a preoperative risk analysis of the patient and staging of the tumor are necessary to reduce postoperative mortality and to identify those patients who will benefit from primary surgery. A risk analysis includes the recording of cardiac, pulmonary, renal, hepatic and cerebral functions, and defines the functional limits of the various systems. Preoperatively it is most important to assess whether the primary tumor is completely resectable or not, because only patients undergoing complete tumor resection benefit from surgery with respect to the long-term prognosis. It is necessary to undertake a classification on the basis of tumor localization and local infiltration, which today can most reliably be evaluated by endoscopic ultrasonography. Advanced tumors above the bifurcation are associated with early infiltration of the tracheobronchial system, and should therefore receive preoperative treatment with combined radiotherapy and chemotherapy. Below the bifurcation, only T4-tumors invading neighboring structures should receive this pretreatment, whereas all others can be resected primarily.

摘要

相似文献

1
Preoperative staging and risk analysis in esophageal carcinoma.
Hepatogastroenterology. 1990 Aug;37(4):382-7.
2
Current strategy in surgery for esophageal cancer.食管癌手术的当前策略。
Ann Ital Chir. 1992 Jan-Feb;63(1):13-8.
3
Endoscopic ultrasonography in the diagnosis of esophageal carcinoma, with particular regard to staging it for operability.内镜超声检查在食管癌诊断中的应用,尤其在评估其手术可切除性分期方面。
Endoscopy. 1986 Sep;18 Suppl 3:22-5. doi: 10.1055/s-2007-1018437.
4
Preoperative TNM classification of esophageal carcinoma by endosonography.通过超声内镜对食管癌进行术前TNM分期
Hepatogastroenterology. 1990 Aug;37(4):376-81.
5
Individualized surgical strategies for cancer of the esophagogastric junction.食管胃交界部癌的个体化手术策略
Ann Chir Gynaecol. 2000;89(3):191-8.
6
[Results of preoperative radio-chemotherapy in locally advanced squamous epithelial cancer of the esophagus].[局部晚期食管鳞状上皮癌术前放化疗的结果]
Chirurg. 1993 Sep;64(9):701-7; discussion 707-8.
7
Esophageal ultrasound and the preoperative staging of carcinoma of the esophagus.
J Thorac Cardiovasc Surg. 1991 Mar;101(3):536-43; discussion 543-4.
8
Preoperative irradiation for carcinoma of the esophagus.
Surg Gynecol Obstet. 1986 Feb;162(2):174-6.
9
[The effect of preoperative radiation therapy on the results of the combined treatment of esophageal cancer].[术前放射治疗对食管癌综合治疗效果的影响]
Med Radiol (Mosk). 1991;36(11):26-30.
10
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.一项针对局部晚期食管肿瘤进行新辅助化疗后行食管切除术的II期试验的长期结果。
Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

引用本文的文献

1
Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.病理分期为T1和T2的食管鳞状细胞癌淋巴结清扫的最佳范围
Front Oncol. 2021 May 25;11:619556. doi: 10.3389/fonc.2021.619556. eCollection 2021.
2
Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.淋巴结阴性食管鳞状细胞癌患者切除淋巴结数量的预后价值
Int J Clin Exp Pathol. 2020 Mar 1;13(3):597-606. eCollection 2020.
3
Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study.
伴有或不伴有标准两野淋巴结清扫的鳞状细胞癌全食管切除术——一项前瞻性研究
Indian J Surg Oncol. 2013 Dec;4(4):336-40. doi: 10.1007/s13193-013-0264-5. Epub 2013 Aug 31.
4
Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?
Jpn J Thorac Cardiovasc Surg. 1999 Aug;47(8):361-7. doi: 10.1007/BF03218027.
5
[Multimodal therapy or surgery alone in adenocarcinoma of the esophagus?].[多模式治疗还是单纯手术治疗食管癌?]
Strahlenther Onkol. 1997 Sep;173(9):486-7. doi: 10.1007/BF03038190.
6
Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus.胸段食管癌行食管次全切除术加三野淋巴结清扫术的长期结果。
Ann Surg. 1994 Mar;219(3):310-6. doi: 10.1097/00000658-199403000-00012.
7
Staging of squamous esophageal cancer: accuracy and value.食管鳞状细胞癌的分期:准确性与价值
World J Surg. 1994 May-Jun;18(3):312-20. doi: 10.1007/BF00316809.
8
A prediction of hospital mortality after surgical treatment for esophageal cancer.
Surg Today. 1994;24(2):122-7. doi: 10.1007/BF02473392.
9
The thoracic esophagus: sectional anatomy and radiosurgical applications.
Surg Radiol Anat. 1991;13(4):313-21. doi: 10.1007/BF01627765.